Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Drop in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 39,900 shares, a decline of 19.9% from the November 30th total of 49,800 shares. Based on an average daily volume of 34,600 shares, the days-to-cover ratio is currently 1.2 days.

Ocean Biomedical Price Performance

Shares of NASDAQ:OCEAW traded up $0.00 during midday trading on Friday, reaching $0.03. The company’s stock had a trading volume of 17,969 shares, compared to its average volume of 40,811. The business has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.04. Ocean Biomedical has a 1 year low of $0.02 and a 1 year high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.